Drug interactions
Glecaprevir / pibrentasvir + Pitavastatin
Severity: Major
Glecaprevir / pibrentasvir and Pitavastatin: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Glecaprevir/pibrentasvir increases pitavastatin exposure, raising the risk of myopathy and rhabdomyolysis. Use is generally limited by the labeling for the HCV regimen.
What this interaction means in plain words
Glecaprevir / pibrentasvir and Pitavastatin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Why it happens
Inhibition of OATP1B1/1B3 reduces hepatic uptake of pitavastatin.
What to do
Avoid the combination where possible, or hold pitavastatin during HCV therapy. If continued, use the lowest dose and monitor for muscle symptoms.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Glecaprevir / pibrentasvir and Pitavastatin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Pitavastatin
- Cyclosporine + Pitavastatin Contraindicated
- Cyclosporin + Pitavastatin Contraindicated
- Erythromycin base + Pitavastatin Major
- Erythromycin ethylsuccinate + Pitavastatin Major
- Erythromycin lactobionate + Pitavastatin Major
- Erythromycin stearate + Pitavastatin Major
Frequently asked questions
Can I take Glecaprevir / pibrentasvir with Pitavastatin?
MediHelp rates the interaction as major. Glecaprevir / pibrentasvir and Pitavastatin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Glecaprevir/pibrentasvir increases pitavastatin exposure, raising the risk of myopathy and rhabdomyolysis. Use is generally limited by the labeling for the HCV regimen.
How serious is the interaction between Glecaprevir / pibrentasvir and Pitavastatin?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible, or hold pitavastatin during HCV therapy. If continued, use the lowest dose and monitor for muscle symptoms.
What other medicines interact with Pitavastatin?
MediHelp also lists interactions of Pitavastatin with, for example, Cyclosporine, Cyclosporin, Erythromycin base. The full list is on the Pitavastatin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
